Clinical trial registry record

Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)

A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Registry ID
NCT06463743
Last registry update
November 21, 2025
Status
Recruiting
Phase
PHASE2
Sponsor
State University of New York at Buffalo
Enrollment
30
Countries
United States
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record matched · 80% confidence

Published automatically with 80% topic confidence after controlled-term evaluation.

  • Metformin · 80%Legacy trial evaluated automatically against controlled title, summary, and longevity-context rules.

Source quality 100% · freshness 85%. These are automated routing signals, not medical or evidence-strength ratings.